✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › Ganciclovir sodium

Ganciclovir sodium

CAS 107910-75-8C9H12N5NaO4MW 277.21

Ganciclovir sodium (CAS 107910-75-8) — formula C9H12N5NaO4, molecular weight 277.21; category organic chemicals.

Product Overview

CAS Number107910-75-8
Molecular FormulaC9H12N5NaO4
Molecular Weight277.21
CategoryOrganic Chemicals

Technical Profile

What this product is

Ganciclovir sodium is a carbon-based organic compound with CAS registry number 107910-75-8 and molecular formula C9H12N5NaO4 (molecular weight 277.21), belonging to the organic chemicals segment of chemical raw materials.

Identification

CAS number: 107910-75-8

Its molecular formula C9H12N5NaO4 comprises 9 C, 12 H, 5 N, 1 Na, 4 O atoms.

Also known as: Ganciclovir sodium · 更昔洛韦钠

Category: organic chemicals

Frequently Asked Questions

What is the CAS number of Ganciclovir sodium?

The CAS registry number of Ganciclovir sodium is 107910-75-8.

What is the molecular formula and molecular weight of Ganciclovir sodium?

Molecular formula C9H12N5NaO4, molecular weight 277.21.

What other names is Ganciclovir sodium known by?

It is also registered under: Ganciclovir sodium, 更昔洛韦钠.

Which category does Ganciclovir sodium belong to?

Category: Organic Chemicals.

PubChem Public Data

Independent reference data for Ganciclovir sodium (CAS 107910-75-8), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number107910-75-8
PubChem CID23700083
Molecular formulaC9H12N5NaO4
IUPAC namesodium 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)purin-6-olate
UNII (FDA)02L083W284

Computed descriptors

Molecular Weight277.21
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count5
Exact Mass277.07869816
Monoisotopic Mass277.07869816
Topological Polar Surface Area142
Heavy Atom Count19

Documented uses on record

    Ganciclovir (injection) is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of cytomegalovirus retinitis (CMV retinitis) in adults who are immunocompromised, including individuals with AIDS. Ganciclovir (injection) is also FDA-approved for the prevention of CMV disease in recipients of organ transplants who are at risk for CMV diseases.CMV diseases, including CMV retinitis, can be opportunistic infections (OIs) of HIV.

    Synonyms and trade names

    GANCICLOVIR SODIUM; 107910-75-8; Ganciclovir Sodium Salt; Cytovene IV; Cytovene-IV; RS-21592 sodium; Ganciclovir (as sodium); DTXSID20883175; DHPG Sodium; GCV Sodium; 02L083W284; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine, monosodium salt; denosine; RefChem:56510; DTXCID201022732; BW-759

    GHS hazard classification

    Reported hazard statementsH350 (100%), H360 (100%)

    H350 (100%): May cause cancer [Danger Carcinogenicity]

    H360 (100%): May damage fertility or the unborn child [Danger Reproductive toxicity]

    What the public record says

    Ganciclovir sodium · CAS 107910-75-8 · C9H12N5NaO4. UNII 02L083W284.

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 更昔洛韦钠

鲁ICP备19031700号-2